Informations sur le produit
Nom :
BCI-215
Synonymes :
- 1H-Inden-1-one, 5-bromo-3-(cyclohexylamino)-2,3-dihydro-2-(phenylmethylene)-, (2E)-
- (2E)-5-Bromo-3-(cyclohexylamino)-2,3-dihydro-2-(phenylmethylene)-1H-inden-1-one
Description :
BCI-215 is a small molecule inhibitor of the extracellular phosphatase, which is an enzyme that dephosphorylates proteins. It has been shown to inhibit the growth of cancer cells. BCI-215 has also been shown to inhibit the activation of mammalian cells, and it can be used in tumorigenicity studies. BCI-215 activates MAP kinase activity in mammalian cells and inhibits growth factor receptor tyrosine kinases. BCI-215 has been targeted for profiling by high throughput screening methods using phosphatases as bait molecules. This drug has demonstrated a phenotype of activating cellular signaling pathways through protein phosphorylation and inhibition of extracellular phosphatases.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
396.32 g/mol
Formule :
C22H22BrNO
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
